These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24864169)

  • 21. Mycoplasma pneumoniae infection in hospitalized adult patients with community-acquired pneumonia in China.
    Shangguan Z; Sun Q; Zhang M; Ding J; Yi L; Gao Y; Zhan A; Zhao R; Ci X
    J Infect Dev Ctries; 2014 Oct; 8(10):1259-66. PubMed ID: 25313601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia].
    Sáez-Llorens X; Castaño E; Wubbel L; Castrejón MM; de Morales I; Vallarino D; de Atencio I; Muñiz L; Olsen K; McCracken GH
    Rev Med Panama; 1998 Sep; 23(2):27-33. PubMed ID: 11214557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 50 Years Ago in The Journal of Pediatrics: Mycoplasma pneumoniae (Eaton Atypical Pneumonia Agent) in Children's Respiratory Infections.
    Toltzis P
    J Pediatr; 2015 May; 166(5):1207. PubMed ID: 25919730
    [No Abstract]   [Full Text] [Related]  

  • 24. Pulmonary embolism associated with mycoplasma in a child.
    Chen S; Ding Y; Vinturache A; Gu H; Lu M; Ding G
    Lancet Infect Dis; 2020 Nov; 20(11):1347. PubMed ID: 33098782
    [No Abstract]   [Full Text] [Related]  

  • 25. Empirical treatment of nonsevere community-acquired pneumonia: still a difficult issue.
    Torres A; Ausina V
    Eur Respir J; 1995 Dec; 8(12):1996-8. PubMed ID: 8666092
    [No Abstract]   [Full Text] [Related]  

  • 26. Mycoplasma pneumoniae infection presenting as haemolytic anaemia.
    Chan LY; Chan JC
    Br J Hosp Med; 1997 Aug 20-Sep 2; 58(4):170. PubMed ID: 9373409
    [No Abstract]   [Full Text] [Related]  

  • 27. Community-acquired macrolide-resistant Mycoplasma pneumoniae pneumonia in patients more than 18 years of age.
    Miyashita N; Maruyama T; Kobayashi T; Kobayashi H; Taguchi O; Kawai Y; Yamaguchi T; Ouchi K; Oka M
    J Infect Chemother; 2011 Feb; 17(1):114-8. PubMed ID: 20676912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical pneumonia.
    Basarab M; Macrae MB; Curtis CM
    Curr Opin Pulm Med; 2014 May; 20(3):247-51. PubMed ID: 24626238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of meningoencephalitis associated with macrolide-resistant Mycoplasma pneumoniae infection.
    Koga S; Ishiwada N; Honda Y; Okunushi T; Hishiki H; Ouchi K; Kohno Y
    Pediatr Int; 2012 Oct; 54(5):724-6. PubMed ID: 23005909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance.
    Cao B; Qu JX; Yin YD; Eldere JV
    Clin Respir J; 2017 Jul; 11(4):419-429. PubMed ID: 26365811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Community-acquired pneumonia and lower respiratory infections.
    Aronson MD
    Compr Ther; 1984 Jun; 10(6):7-12. PubMed ID: 6734135
    [No Abstract]   [Full Text] [Related]  

  • 32. [
    Dumoulin A
    Rev Med Suisse; 2016 Oct; 12(534):1694-1697. PubMed ID: 28686393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical presentation of Legionella pneumonia: Evaluation of clinical scoring systems and therapeutic efficacy.
    Miyashita N; Higa F; Aoki Y; Kikuchi T; Seki M; Tateda K; Maki N; Uchino K; Ogasawara K; Kiyota H; Watanabe A
    J Infect Chemother; 2017 Nov; 23(11):727-732. PubMed ID: 28951197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mycoplasma pneumoniae respiratory infections].
    Dupont B
    Soins; 1982 Oct; (391):25-30. PubMed ID: 6818690
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular characterization of macrolide resistance of a Mycoplasma pneumoniae strain that developed during therapy of a patient with pneumonia.
    Dumke R; Stolz S; Jacobs E; Juretzek T
    Int J Infect Dis; 2014 Dec; 29():197-9. PubMed ID: 25449256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial therapy in community-acquired pneumonia among emergency patients in a university hospital in Japan.
    Kawai S; Ochi M; Nakagawa T; Goto H
    J Infect Chemother; 2004 Dec; 10(6):352-8. PubMed ID: 15614461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China].
    Yin YD; Cao B; Wang H; Wang RT; Liu YM; Gao Y; Qu JX; Han GJ; Liu YN
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):954-8. PubMed ID: 24503430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Microbiology of atypical community-acquired pneumonia. Clinical needs and contribution of new antibiotics].
    García-Rodríguez JA; Muñoz JL; Alonso MA; Gutiérrez N
    Enferm Infecc Microbiol Clin; 1998 Dec; 16 Suppl 2():22-30; discussion 47-52. PubMed ID: 10344095
    [No Abstract]   [Full Text] [Related]  

  • 39. [Atypical pneumonias (mycoplasmic, chlamydial and legionellous)].
    Sokolova VI
    Antibiot Khimioter; 2007; 52(11-12):35-40. PubMed ID: 19275056
    [No Abstract]   [Full Text] [Related]  

  • 40. C-reactive protein for discriminating treatment failure from slow responding pneumonia.
    Ruiz-González A; Falguera M; Porcel JM; Martínez-Alonso M; Cabezas P; Geijo P; Boixeda R; Dueñas C; Armengou A; Capdevila JA; Serrano R
    Eur J Intern Med; 2010 Dec; 21(6):548-52. PubMed ID: 21111942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.